捷克共和国累积药敏谱编制建议草案
本文指出细菌耐药性极端增加使重症监护室和社区的抗生素治疗更加困难,为维持现有抗生素疗效,需跨学科合作以确保抗生素仅用于治疗细菌感染而非自然细菌定植。抗生素管理已成为伦理要求,累积药敏谱是其核心要素之一,可帮助在患者结果未回时合理选择初始抗生素。然而累积药敏谱的编制尚未明确定义,仅有两条美国指南且不符合住院患者临床微生物学需求。文章旨在基于唯一的CLSI指南和捷克共和国编制建议草案,介绍累积药敏谱编制的潜在陷阱。
要点
- 累积药敏谱是抗生素管理的核心要素之一,可帮助在患者结果未回时合理选择初始抗生素。
- 累积药敏谱的编制尚未明确定义,仅有两条美国指南且不符合住院患者临床微生物学需求。
- 细菌耐药性极端增加使重症监护室和社区的抗生素治疗更加困难,需跨学科合作确保抗生素仅用于治疗细菌感染而非自然细菌定植。
研究设计与关键结果
- 文章旨在基于唯一的CLSI指南和捷克共和国编制建议草案,介绍累积药敏谱编制的潜在陷阱。
- 仅有两条美国指南可用于累积药敏谱编制,且不符合住院患者临床微生物学需求。
证据类型、等级与局限
- 证据类型:指南草案。
对床旁实践的改变
- 累积药敏谱可帮助在患者结果未回时合理选择初始抗生素。
- 抗生素管理已成为伦理要求,累积药敏谱是其核心要素之一。
指南或共识出处
- CLSI指南
- 捷克共和国累积药敏谱编制建议草案
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
In today's medicine, one of the main challenges is an extreme increase in bacterial resistance, making antibiotic treatment in both intensive care units and in the community considerably more difficult. To maintain the efficacy of existing antibiotics, close interdisciplinary cooperation is crucial for diagnosing infectious diseases as well as for selecting appropriate antibiotics so that these are only used for treating bacterial infections, not natural bacterial colonization. Antibiotic stewardship has become an ethical imperative, with cumulative antibiograms being one of its core elements. Cumulative antibiograms help with rational choice of antibiotics for initial therapy when the patient's results are still pending. However, preparation of cumulative antibiograms is not clearly defined. Only two American guidelines are available that do not correspond with the needs of clinical microbiology in hospitalized patients. The article aims to present the potential pitfalls of preparing cumulative antibiograms based on the only CLSI guidelines and a draft of recommendation for their preparation in the Czech Republic.
参考来源
- Adámková V. [Draft recommendation for preparation of cumulative antibiograms in the Czech Republic]. Klin Mikrobiol Infekc Lek. 2021. PMID: 35170746
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。